Smith & Nephew stock receives consensus “hold” rating: 4 takeaways

MarketBeat reports that Smith & Nephew stock has been given a consensus rating of “hold” by the 16 firms currently covering the firm, according to a Dakota Financial News report.

Advertisement

Here are four takeaways:

 

1. The average 12-month price target for the stock among brokerages is $18.76.

 

2. The company’s market capitalization is $153,981.

 

3. The company’s 50 day moving average is $17.66 and its 200-day moving average is $17.45.

 

4. Smith & Nephew has a one-year low of $13.46 and a one-year high of $18.58.

 

More articles on devices:
Next generation intellijoint HIP successfully used in first surgeries: 3 things to know
Medtronic dominates European VCF market — 8 trends to watch
Titan Spine signs distribution agreement for Europe: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.